PAM
DWTX

PVG Asset Management’s Dogwood Therapeutics DWTX Stock Holding History

PVG Asset Management’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,224
Closed -$29.6K – 56
2023
Q1 		$29.6K Hold
3,224
– – 0.09% 38
2022
Q4 		$19K Hold
3,224
– – 0.08% 33
2022
Q3 		$30.7K Buy
+3,224
New +$454K 0.12% 34
2021
Q2 		– Sell
-2,206
Closed -$316K – 70
2021
Q1 		$316K Buy
+2,206
New +$384K 1% 21

Other funds holding DWTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

PVG Asset Management's DWTX Position: Q2 2023 in Review

PVG Asset Management sold out of Dogwood Therapeutics (DWTX) in Q2 2023, closing a stake of 3,224 shares — an estimated $29.6K sold.

PVG Asset Management first reported a position in DWTX in Q1 2021 and held it in 4 quarters. The position peaked at $316K in Q1 2021. 24 funds tracked by Wall St. Rank hold DWTX as of Q2 2023.

  • PVG Asset Management reported no remaining Dogwood Therapeutics position as of Q2 2023 after selling out during the quarter.
  • PVG Asset Management sold 3,224 Dogwood Therapeutics shares in Q2 2023, an estimated $29.6K.
  • PVG Asset Management first reported a position in Dogwood Therapeutics in Q1 2021 and held it in 4 quarters.
  • PVG Asset Management's Dogwood Therapeutics position peaked at $316K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2023.

Based on PVG Asset Management's 13F filing for Q2 2023, filed 31 Jul 2023.